Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine

被引：58

作者：

Friedman, J

Ault, K

Powchik, P

机构：

[1] Department of Psychiatry, Mount Sinai Medical Center, New York, NY

[2] Department of Psychiatry, Mount Sinai Medical Center, New York

来源：

BIOLOGICAL PSYCHIATRY | 1997年 / 42卷 / 06期

关键词：

clozapine; pimozide; schizophrenia; antipsychotic; augmenting;

D O I：

10.1016/S0006-3223(97)00227-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

收藏

页码：522 / 523

页数：2

相关论文

共 6 条

[1] BUTYROPHENONE INFLUENCES ON OPIATE RECEPTOR
CREESE, I
FEINBERG, AP
SNYDER, SH
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 36 (01) : 231 - 235
[2] OPLER LA, 1991, J CLIN PSYCHIAT, V52, P221
[3] PIMOZIDE - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USES IN PSYCHIATRY
PINDER, RM
BROGDEN, RN
SAWYER, PR
SPEIGHT, TM
SPENCER, R
AVERY, GS
[J]. DRUGS, 1976, 12 (01) : 1 - 40
[4] ROTH RH, 1979, COMMUN PSYCHOPHARMAC, V3, P429
[5] DIFFERENTIAL MODULATION OF DOPAMINE-D2 RECEPTORS BY CHRONIC HALOPERIDOL, NITRENDIPINE, AND PIMOZIDE
TECOTT, LH
KWONG, LL
UHR, S
PEROUTKA, SJ
[J]. BIOLOGICAL PSYCHIATRY, 1986, 21 (12) : 1114 - 1122
[6] CLINICAL USES OF PIMOZIDE
TUETH, MJ
CHEONG, JA
[J]. SOUTHERN MEDICAL JOURNAL, 1993, 86 (03) : 344 - 349